WASHINGTON, Oct. 2, 2014 /PRNewswire/ — The Corporate Whistleblower Center is urging in-home healthcare managers, or hospice managers to call them at 866-714-6466 if they possess proof their company is involved in widespread Medicare fraud involving billing for services that were never rendered, because the Center believes this is a gigantic problem that needs to be fixed. The Center also believes the reward potential for this type of information can be substantial provided the wrongdoing is well documented. http://CorporateWhistleblowerCenter.Com
Photo – http://photos.prnewswire.com/prnh/20141001/149671
Photo – http://photos.prnewswire.com/prnh/20141001/149672
The Corporate Whistleblower Center says, "If you are a manager for an in-home healthcare provider, or a hospice service provider, and you have well documented proof your company is systematically overbilling Medicare for services never rendered please call us at 866-714-6466, so we can try to explain federal whistleblower programs to you, and how they work.
"As long as the wrongdoing is easy to see, and the overbilling exceeds one million dollars we will help you package your information, and we will get you to some of the nation's top whistleblower attorneys. We are not aware of any other group that offers this service. http://CorporateWhistleblowerCenter.Com
As an example of this earlier this year, the United States Department of Justice announced a healthcare provider called Amedisys Inc. and its affiliates (Amedisys) agreed to pay $150 million to the federal government to resolve allegations that they violated the False Claims Act by submitting false home healthcare billings to the Medicare program.
Amedisys allegedly billed Medicare for nursing and therapy services that were medically unnecessary or provided to patients who were not homebound, and otherwise misrepresented patients' conditions to increase its Medicare payments. These billing violations were the alleged result of management pressure on nurses and therapists to provide care based on the financial benefits to Amedisys, rather than the needs of patients.
According to the Justice Department, "In this instance the whistleblowers – primarily former Amedisys employees – will collectively split over $26 million."
Simple rules for a whistleblower from the Corporate Whistleblower Center:
- Do not go to the government first if you are a major whistleblower. The Corporate Whistleblower Center says, "Major whistleblowers frequently go to the federal government thinking they will help. It's a huge mistake."
- Do not go to the news media with your whistleblower information. Public revelation of a whistleblower's information could destroy any prospect for a reward.
- Do not try to force a government contractor or corporation to come clean to the government about their wrongdoing. The Corporate Whistleblower Center says, "Fraud is so rampant among federal contractors that any suggestion of exposure might result in an instant job termination, or harassment of the whistleblower. Come to us first, tell us what type of information you have, and if we think it's sufficient, we will help find the right law firms to assist in advancing your information."
- The Corporate Whistleblower Center wants to emphasize there are high quality whistleblowers in every state including California, New York, Florida, Texas, Massachusetts, Maryland, Rhode Island, Virginia, Ohio, Pennsylvania, West Virginia, Tennessee, North Carolina, Georgia, Alabama, Louisiana, Missouri, Michigan, Indiana, Iowa, Illinois, Wisconsin, Minnesota, Nebraska, North Dakota, Kansas, New Mexico, Colorado, Utah, Arizona, Nevada, Idaho, Washington, and Alaska.
Any type of insider or employee who possesses significant proof of their employer or a government contractor defrauding the federal government is encouraged to contact Corporate Whistleblower Center anytime at 866-714-6466 or via their web site at http://CorporateWhistleblowerCenter.Com
For attribution please refer to the April 2014 United States Department of Justice press release on this matter: http://www.justice.gov/opa/pr/2014/April/14-civ-422.html
The lawsuits are captioned United States ex rel. CAF Partners et al. v. Amedisys, Inc. et al. 10-cv-2323 (E.D. Pa.); United States ex rel. Brown v. Amedisys, Inc. et al., 13-cv-2803 (E.D. Pa.);United States ex rel. Umberhandt v. Amedisys, Inc., 13-cv-2789 (E.D. Pa.); United States ex rel. Doe et al. v. Amedisys, Inc., 13-cv-3187 (E.D. Pa.); United States ex rel. Ognen et al. v. Amedisys, Inc. et al. 13-cv-4232 (E.D. Pa.); United States ex rel. Lewis v. Amedisys, Inc., 13-cv-3359 (E.D. Pa.); and United States ex rel. Natalie Raven et al. v. Amedisys, Inc. et al
Contact:
M. Thomas Martin
866-714-6466